首页 | 本学科首页   官方微博 | 高级检索  
     

脑栓通胶囊对缺血性中风患者随访半年生存质量指标评分变化的影响
引用本文:叶晓勤,谢雁鸣,邹忆怀,赵性泉,韩舰华,王新志,马云枝,毕齐,解庆凡,赵建军,曹晓岚,陈红霞,王诗忠,闫咏梅,韩祖成,易丹辉,王永炎. 脑栓通胶囊对缺血性中风患者随访半年生存质量指标评分变化的影响[J]. 中国中药杂志, 2015, 40(21): 4297-4300
作者姓名:叶晓勤  谢雁鸣  邹忆怀  赵性泉  韩舰华  王新志  马云枝  毕齐  解庆凡  赵建军  曹晓岚  陈红霞  王诗忠  闫咏梅  韩祖成  易丹辉  王永炎
作者单位:中国中医科学院中医临床基础医学研究所, 北京 100700;安徽中医药大学中医临床学院, 安徽合肥 230038,中国中医科学院中医临床基础医学研究所, 北京 100700,北京中医药大学东直门医院, 北京 100007,首都医科大学附属天坛医院, 北京 100050,天津中医药大学第二附属医院, 天津 300210,河南中医学院第一附属医院, 河南郑州 450003,河南中医学院第一附属医院, 河南郑州 450003,首都医科大学附属安贞医院, 北京 100029,邢台市人民医院, 河北邢台 054031,长春中医药大学附属医院, 吉林长春 130021,山东中医药大学第二附属医院, 山东济南 250011,广州中医药大学第二附属医院, 广东广州 510120,福建中医药大学第二附属医院, 福建福州 350003,陕西中医学院附属医院, 陕西咸阳 712000,陕西省中医医院, 陕西西安 710003,中国人民大学统计学院, 北京 100872,中国中医科学院中医临床基础医学研究所, 北京 100700
基金项目:国家高新技术研究发展计划(863)项目(2007AA02Z4B2)
摘    要:针对上市药脑栓通胶囊开展上市后再评价,观察其对缺血性中风患者随访6个月后生存质量的影响并对其不良反应进行监测,为缺血性中风患者恢复期二级预防治疗提供借鉴和参考。696例患者来自全国12家三级甲等医院,通过中央随机系统,随机分为2组,试验组344例、对照组352例。试验组给予脑栓通胶囊+肠溶阿司匹林治疗,对照组给予肠溶阿司匹林治疗。连用6个月后观察患者生存质量,同时观察两组不良事件发生率及治疗前后实验室检查结果。结果提示脑栓通胶囊可用于缺血性中风患者恢复期二级预防治疗,较单独使用阿司匹林在患者生存质量的改善方面具有一定的优势,且未发生与脑栓通胶囊相关的不良事件。脑栓通胶囊在治疗缺血性中风恢复期方面是安全有效的。

关 键 词:脑栓通胶囊  缺血性中风  生存质量  随访研究
收稿时间:2015-07-28

Effect of Naoshuantong capsule on change of SSQOL index in patients with ischemic stroke in six mouths follow-up
YE Xiao-qin,XIE Yan-ming,ZOU Yi-huai,ZHAO Xin-quan,HAN Jian-hu,WANG Xin-zhi,MA Yun-zhi,BI Qi,XIE Qin-fan,ZHAO Jian-jun,CAO Xiao-lan,CHEN Hong-xi,WANG Shi-zhong,YAN Yong-mei,HAN Zu-cheng,YI Dan-hui and WANG Yong-yan. Effect of Naoshuantong capsule on change of SSQOL index in patients with ischemic stroke in six mouths follow-up[J]. China Journal of Chinese Materia Medica, 2015, 40(21): 4297-4300
Authors:YE Xiao-qin  XIE Yan-ming  ZOU Yi-huai  ZHAO Xin-quan  HAN Jian-hu  WANG Xin-zhi  MA Yun-zhi  BI Qi  XIE Qin-fan  ZHAO Jian-jun  CAO Xiao-lan  CHEN Hong-xi  WANG Shi-zhong  YAN Yong-mei  HAN Zu-cheng  YI Dan-hui  WANG Yong-yan
Affiliation:Institute of Basic Research in Clinical Trial, China Academy of Chinese Medical Sciences, Beijing 100700, China;The Clinical College of Anhui University of Traditional Chinese Medicine, Hefei 230038, China,Institute of Basic Research in Clinical Trial, China Academy of Chinese Medical Sciences, Beijing 100700, China,Affiliated Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine, Beijing 100007, China,Affiliated Beijing Tiantan Hospital of Capital Medical University, Beijing 100500, China,The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300210, China,The First Affiliated Hospital of Henan College of Traditional Chinese Medicine, Zhengzhou 450003, China,The First Affiliated Hospital of Henan College of Traditional Chinese Medicine, Zhengzhou 450003, China,Affiliated Anzhen Hospital of Capital Medical University, Beijing 100029, China,Xingtai Renmin Hospital, Xingtai 054031, China,Affiliated Hospital of Changchun University of Traditional Chinese Medicine, Changchun 130021, China,The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250011, China,The Second Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou 510120, China,The Second Affiliated Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou 350003, China,Affiliated Hospital of Shanxi College of Traditional Chinese Medicine, Xianyang 712000, China,Chinese Medicine Hospital of Shaanxi Province, Xi'an 710003, China,School of Statistics, Renmin University of China, Beijing 100872, China and Institute of Basic Research in Clinical Trial, China Academy of Chinese Medical Sciences, Beijing 100700, China
Abstract:
Keywords:Naoshuantong capsule  ischemic stroke  quality of life  follow-up studies
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号